3M spinning off healthcare division, launching new company

After a 70-year run, multinational science conglomerate 3M’s healthcare wing is spinning off into an independent company.

In a statement, 3M announced that the new independent healthcare company will be named Solventum, which the company said derives from the words "solving" and "momentum.” 

The name change will be implemented when the spinoff of the independent healthcare company occurs, expected in the first half of 2024, pending final approval by 3M's board of directors and meeting other necessary conditions, such as approval by regulators and shareholders.

Until the breakaway is complete, 3M’s healthcare business will remain part of the core company, continuing its focus on producing products in clinical safety and sanitation, wound care, oral care, filtration and more.

According to 3M, Solventum will employ more than 20,000 people at launch. It’s not clear yet if the launch of a new company will shift the core focus of the current 3M healthcare business. 

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.